Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 27737878

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Immunol Res
Publication date
2016 Nov
First author
Roemer MG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Roemer MG
      type
      Author
    2. name
      Advani RH
      type
      Author
    3. name
      Redd RA
      type
      Author
    4. name
      Pinkus GS
      type
      Author
    5. name
      Natkunam Y
      type
      Author
    6. name
      Ligon AH
      type
      Author
    7. name
      Connelly CF
      type
      Author
    8. name
      Pak CJ
      type
      Author
    9. name
      Carey CD
      type
      Author
    10. name
      Daadi SE
      type
      Author
    11. name
      Chapuy B
      type
      Author
    12. name
      de Jong D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Roemer MG
      type
      Author
    2. name
      Advani RH
      type
      Author
    3. name
      Redd RA
      type
      Author
    4. name
      Pinkus GS
      type
      Author
    5. name
      Natkunam Y
      type
      Author
    6. name
      Ligon AH
      type
      Author
    7. name
      Connelly CF
      type
      Author
    8. name
      Pak CJ
      type
      Author
    9. name
      Carey CD
      type
      Author
    10. name
      Daadi SE
      type
      Author
    11. name
      Chapuy B
      type
      Author
    12. name
      de Jong D
      type
      Author
    bibliography ids
    1. nci-bib-424df80eb102657782341bba
    book metadata
    content sha256
    9969d2cd8d665c563fb41a2010d2b4fb3632a610697aa724aeb28b3f947db07d
    document type
    citation
    dois
    1. 10.1158/2326-6066.CIR-16-0201
    electronic publication date
    display
    2016 Oct 13
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27737878
    immutable id
    pubmed:27737878@9969d2cd8d665c563fb41a2010d2b4fb3632a610697aa724aeb28b3f947db07d
    journal
    abbreviation
    Cancer Immunol Res
    issn electronic
    2326-6074
    issn print
    2326-6066
    issue
    11
    name
    Cancer immunology research
    nlm unique id
    101614637
    pages
    910-916
    volume
    4
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27737878
      provenance
      batch id
      d649bcb2d98dbbacd53c
      provider
      NCBI PubMed ESummary
      record sha256
      7c9c3383fa111f698636341d8ed56fd613af38e1f514efb0e6ed0dc55f7610b3
      response sha256
      26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
      retrieved at
      2026-09-09T23:47:20.761544+00:00
      publication date
      display
      2016 Nov
      precision
      month
      year
      2016
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27737878/
      title
      Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.

      Preserved source evidence · Independent clinical review pending · Not medical advice